Table 3.
Comparison between Active and Inactive MNVs
| MNV Type | Wavelength | GEFC Intensity | REFC Intensity |
|---|---|---|---|
| Active | 575.9 ± 2.9 | 84.6 ± 47.0 | 87.3 ± 45.2 |
| + SRF | 575.9 ± 2.6a | 97.9 ± 47.5 | 101.8 ± 44.8 |
| + IRF | 575.9 ± 3.6b | 58.0 ± 33.5c,d | 58.2 ± 30.0e |
| Inactive | 581.0 ± 6.7 | 31.9 ± 23.7e | 36.3 ± 22.7e |
| P valuef | <0.001 | <0.001 | <0.001 |
a
Comparison versus inactive MNVs: Scheffé's test, P < 0.001.
b
Comparison versus inactive MNVs: Scheffé's test, P = 0.005.
c
Comparison versus inactive MNVs: Scheffé's test, P = 0.05.
d
Comparison versus active MNVs + SRF: Scheffé's test, P = 0.002.
e
Comparison versus active MNVs + SRF: Scheffé's test, P < 0.001.
f
Two-way ANOVA analyses: comparison between patients with active and inactive MNV. Statistical significance was set at P = 0.05. Values are reported as mean ± SD.